By combining the current prostate specific antigen (PSA) test with the new test (the circulating tumour cell (CTC) test, this could help men avoid unnecessary and invasive biopsies, over-diagnosis and over-treatment.
This is a companion discussion topic for the original article at https://patient.info/news-and-features/can-blood-tests-identify-prostate-cancer